Composition analysis of Compound Shenhua Tablet, a seven-herb Chinese medicine for IgA nephropathy: evaluation of analyte-capacity of the assays

IF 4 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Chinese Journal of Natural Medicines Pub Date : 2024-02-01 DOI:10.1016/S1875-5364(24)60553-4
Haiyan ZHANG , Qiuyue WANG , Jianan WANG , Sichao ZHANG , Weiwei JIA , Ning HE , Xiaoyan XIA , Ting WANG , Liyu LAI , Jiaying LI , Jing DU , Olajide E. OLALEYE , Xiangmei CHEN , Junling YANG , Chuan LI
{"title":"Composition analysis of Compound Shenhua Tablet, a seven-herb Chinese medicine for IgA nephropathy: evaluation of analyte-capacity of the assays","authors":"Haiyan ZHANG ,&nbsp;Qiuyue WANG ,&nbsp;Jianan WANG ,&nbsp;Sichao ZHANG ,&nbsp;Weiwei JIA ,&nbsp;Ning HE ,&nbsp;Xiaoyan XIA ,&nbsp;Ting WANG ,&nbsp;Liyu LAI ,&nbsp;Jiaying LI ,&nbsp;Jing DU ,&nbsp;Olajide E. OLALEYE ,&nbsp;Xiangmei CHEN ,&nbsp;Junling YANG ,&nbsp;Chuan LI","doi":"10.1016/S1875-5364(24)60553-4","DOIUrl":null,"url":null,"abstract":"<div><p>Compound Shenhua Tablet, a medicine comprising seven herbs, is employed in treating IgA nephropathy. This study aimed to meticulously analyze its chemical composition. Based on a list of candidate compounds, identified through extensive literature review pertinent to the tablet's herbal components, the composition analysis entailed the systematic identification, characterization, and quantification of the constituents. The analyte-capacity of LC/ESI-MS-based and GC/EI-MS-based assays was evaluated. The identified and characterized constituents were quantified to determine their content levels and were ranked based on the constituents' daily doses. A total of 283 constituents, classified into 12 distinct categories, were identified and characterized in the Compound Shenhua Tablet. These constituents exhibited content levels of 1–10 982 μg·g<sup>−1</sup>, with daily doses of 0.01–395 μmol·d<sup>−1</sup>. The predominant constituents, with daily doses of ≥ 10 μmol·d<sup>−1</sup>, include nine organic acids (citric acid, quinic acid, chlorogenic acid, cryptochlorogenic acid, gallic acid, neochlorogenic acid, isochlorogenic acid C, isochlorogenic acid B, and linoleic acid), five iridoids (specnuezhenide, nuezhenoside G13, nuezhenidic acid, secoxyloganin, and secologanoside), two monoterpene glycosides (paeoniflorin and albiflorin), a sesquiterpenoid (curzerenone), a triterpenoid (oleanolic acid), and a phenylethanoid (salidroside). Additionally, there were 83, 126, and 55 constituents detected in the medicine with daily doses of 1–10, 0.1–1, and 0.01–0.1 μmol·d<sup>−1</sup>, respectively. The combination of the LC/ESI-MS-based and GC/EI-MS-based assays demonstrated a complementary relationship in their analyte-capacity for detecting the constituents present in the medicine. This comprehensive composition analysis establishes a solid foundation for further pharmacological research on Compound Shenhua Tablet and facilitates the quality evaluation of this complex herbal medicine.</p></div>","PeriodicalId":10002,"journal":{"name":"Chinese Journal of Natural Medicines","volume":"22 2","pages":"Pages 178-192"},"PeriodicalIF":4.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Journal of Natural Medicines","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1875536424605534","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Compound Shenhua Tablet, a medicine comprising seven herbs, is employed in treating IgA nephropathy. This study aimed to meticulously analyze its chemical composition. Based on a list of candidate compounds, identified through extensive literature review pertinent to the tablet's herbal components, the composition analysis entailed the systematic identification, characterization, and quantification of the constituents. The analyte-capacity of LC/ESI-MS-based and GC/EI-MS-based assays was evaluated. The identified and characterized constituents were quantified to determine their content levels and were ranked based on the constituents' daily doses. A total of 283 constituents, classified into 12 distinct categories, were identified and characterized in the Compound Shenhua Tablet. These constituents exhibited content levels of 1–10 982 μg·g−1, with daily doses of 0.01–395 μmol·d−1. The predominant constituents, with daily doses of ≥ 10 μmol·d−1, include nine organic acids (citric acid, quinic acid, chlorogenic acid, cryptochlorogenic acid, gallic acid, neochlorogenic acid, isochlorogenic acid C, isochlorogenic acid B, and linoleic acid), five iridoids (specnuezhenide, nuezhenoside G13, nuezhenidic acid, secoxyloganin, and secologanoside), two monoterpene glycosides (paeoniflorin and albiflorin), a sesquiterpenoid (curzerenone), a triterpenoid (oleanolic acid), and a phenylethanoid (salidroside). Additionally, there were 83, 126, and 55 constituents detected in the medicine with daily doses of 1–10, 0.1–1, and 0.01–0.1 μmol·d−1, respectively. The combination of the LC/ESI-MS-based and GC/EI-MS-based assays demonstrated a complementary relationship in their analyte-capacity for detecting the constituents present in the medicine. This comprehensive composition analysis establishes a solid foundation for further pharmacological research on Compound Shenhua Tablet and facilitates the quality evaluation of this complex herbal medicine.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
治疗 IgA 肾病的七味中药复方神化片的成分分析:检测分析能力评估
复方神化片是一种由七种药材组成的药物,可用于治疗 IgA 肾病。本研究旨在细致分析其化学成分。通过广泛查阅与神华片药材成分相关的文献,确定了一份候选化合物清单,在此基础上,对成分进行了系统的鉴定、表征和定量分析。对基于 LC/ESI-MS 和基于 GC/EI-MS 的分析方法的分析能力进行了评估。对已鉴定和定性的成分进行了定量,以确定其含量水平,并根据成分的日剂量进行排序。在复方神化片中共鉴定和表征了 283 种成分,分为 12 个不同的类别。这些成分的含量水平为 1-10 982 μg-g-1,日剂量为 0.01-395 μmol-d-1。日剂量≥ 10 μmol-d-1 的主要成分包括九种有机酸(柠檬酸、奎宁酸、绿原酸、隐绿原酸、没食子酸、新绿原酸、异绿原酸 C、异绿原酸 B 和亚油酸)、五种虹苷类化合物(芒柄花苷、芒柄花苷 G13、芒柄花苷酸、矢车菊苷和矢车菊苷)、两种单萜苷类化合物(芍药苷和白花蛇舌草苷)、一种倍半萜类化合物(莪术酮)、一种三萜类化合物(齐墩果酸)和一种苯乙醇苷类化合物(水杨梅苷)。此外,在每日剂量为 1-10、0.1-1 和 0.01-0.1 μmol-d-1 的药物中分别检测到 83、126 和 55 种成分。基于 LC/ESI-MS 和基于 GC/EI-MS 的检测方法在检测药物成分的分析能力方面具有互补关系。这项全面的成分分析为进一步开展复方神化片的药理研究奠定了坚实的基础,并有助于对这种复杂的中药材进行质量评价。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Chinese Journal of Natural Medicines
Chinese Journal of Natural Medicines INTEGRATIVE & COMPLEMENTARY MEDICINE-PHARMACOLOGY & PHARMACY
CiteScore
7.50
自引率
4.30%
发文量
2235
期刊介绍: The Chinese Journal of Natural Medicines (CJNM), founded and sponsored in May 2003 by China Pharmaceutical University and the Chinese Pharmaceutical Association, is devoted to communication among pharmaceutical and medical scientists interested in the advancement of Traditional Chinese Medicines (TCM). CJNM publishes articles relating to a broad spectrum of bioactive natural products, leading compounds and medicines derived from Traditional Chinese Medicines (TCM). Topics covered by the journal are: Resources of Traditional Chinese Medicines; Interaction and complexity of prescription; Natural Products Chemistry (including structure modification, semi-and total synthesis, bio-transformation); Pharmacology of natural products and prescription (including pharmacokinetics and toxicology); Pharmaceutics and Analytical Methods of natural products.
期刊最新文献
NO inhibitory constituents from Glycosmis craibii var. glabra Multioxidized polyketides from an endophytic Penicillium sp. YUD17006 associated with Gastrodia elata Dual-function natural products: Farnesoid X receptor agonist/inflammation inhibitor for metabolic dysfunction-associated steatotic liver disease therapy Loganin inhibits the ROS-NLRP3-IL-1β axis by activating the NRF2/HO-1 pathway against osteoarthritis Luteolin ameliorates ulcerative colitis in mice via reducing the depletion of NCR+ILC3 through Notch signaling pathway
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1